Thursday, June 8, 2017
- 1:15pm-2:45pm
-
Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Parkinsonics – A Prospective, Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Non-Motor Symptoms in Idiopathic Parkinson Disease (PD)
Clinical Trials and Therapy in Movement Disorders · Exhibit Hall C
- 1:15pm-2:45pm
-
Patient Engagement in Parkinson’s Research: A Comparison of Attitudes and Impact in the UK and the US
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Patient perspectives of using the ND0612 mini-pump
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Patients affected by functional motor symptoms are not liars: an experimental deception study with the Guilty Knowledge Task
Other · Exhibit Hall C
- 1:15pm-2:45pm
-
Pattern and Predictors Of Tremor In Patients With Primary Dystonia
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Patterns of Striatal DAT Binding Loss in a Progressing Parkinson Disease (PD) Cohort: Four year PPMI Follow-up
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Persistent L-Dopa Responsive Hemiparkinsonism After Cryptococcoal Meningoencephalitis in an Immunocompetent Man
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Pharmacokinetic profile of continuous levodopa/carbidopa delivery when administered subcutaneously (ND0612) versus duodenal infusion (levodopa/carbidopa intestinal gel)
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Physical activity habits in early Parkinson’s disease and healthy controls
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- «Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 41
- Next Page»